As of June 17, 2025, Biosyent Inc (RX.V) reports a Forward P/E of 14.38.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Biosyent Inc's Forward P/E to Peers
To better understand Biosyent Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Biosyent Inc (RX.V) | 14.38 |
| Cipher Pharmaceuticals Inc (CPH.TO) | 15.43 |
| Cansortium Inc (TIUM.U.CN) | 1.36 |
Compared to its competitors, Biosyent Inc's Forward P/E is about average compared to peers, indicating growth expectations in line with industry peers.